| Primary |
| Hereditary Angioedema |
77.0% |
| Aortic Dissection |
5.1% |
| Enzyme Abnormality |
3.4% |
| Prophylaxis |
2.8% |
| Angioedema |
2.2% |
| Prophylaxis Against Transplant Rejection |
2.2% |
| Gastrointestinal Oedema |
1.1% |
| Polycystic Ovaries |
1.1% |
| Premedication |
1.1% |
| Transplant Rejection |
1.1% |
| C1 Esterase Inhibitor Deficiency |
0.6% |
| Capillary Leak Syndrome |
0.6% |
| Sepsis |
0.6% |
| Stent Placement |
0.6% |
| Tonsillectomy |
0.6% |
|
| Drug Ineffective |
19.4% |
| Hereditary Angioedema |
15.3% |
| Condition Aggravated |
5.6% |
| Laryngeal Oedema |
5.6% |
| Abdominal Distension |
4.2% |
| Impaired Work Ability |
4.2% |
| Maternal Exposure During Pregnancy |
4.2% |
| Pulmonary Embolism |
4.2% |
| Swollen Tongue |
4.2% |
| Thrombosis |
4.2% |
| Yawning |
4.2% |
| Abdominal Pain |
2.8% |
| Abortion Spontaneous |
2.8% |
| Angioedema |
2.8% |
| Axillary Vein Thrombosis |
2.8% |
| Death |
2.8% |
| Drug Ineffective For Unapproved Indication |
2.8% |
| Hepatitis B |
2.8% |
| Inhibiting Antibodies |
2.8% |
| Jugular Vein Thrombosis |
2.8% |
|
| Secondary |
| Hereditary Angioedema |
55.6% |
| Product Used For Unknown Indication |
15.2% |
| Anticoagulant Therapy |
3.5% |
| Type 1 Diabetes Mellitus |
2.9% |
| Urticaria Chronic |
2.9% |
| Wheezing |
2.9% |
| Dyspnoea |
2.3% |
| Insomnia |
2.3% |
| Pain |
2.3% |
| Angioedema |
1.8% |
| Hypertension |
1.8% |
| Prophylaxis |
1.8% |
| Adrenal Insufficiency |
0.6% |
| Angina Pectoris |
0.6% |
| Asthma |
0.6% |
| Bacteraemia |
0.6% |
| Convulsion |
0.6% |
| Enzyme Abnormality |
0.6% |
| Hypersensitivity |
0.6% |
| Nausea |
0.6% |
|
| Hepatitis C Antibody Positive |
40.7% |
| Infusion Related Reaction |
11.1% |
| Malaise |
7.4% |
| Convulsion |
5.6% |
| Pulmonary Embolism |
3.7% |
| Thrombosis |
3.7% |
| Treatment Noncompliance |
3.7% |
| Abortion Spontaneous |
1.9% |
| Angioedema |
1.9% |
| Embolism |
1.9% |
| Feeling Abnormal |
1.9% |
| Liver Disorder |
1.9% |
| No Therapeutic Response |
1.9% |
| Sinusitis |
1.9% |
| Swelling |
1.9% |
| Systemic Candida |
1.9% |
| Therapy Change |
1.9% |
| Urinary Tract Infection |
1.9% |
| Urticaria |
1.9% |
| Vision Blurred |
1.9% |
|
| Concomitant |
| Hereditary Angioedema |
43.5% |
| Product Used For Unknown Indication |
17.9% |
| Pain |
5.3% |
| Prophylaxis |
4.9% |
| Asthma |
4.1% |
| Pregnancy |
4.1% |
| Abdominal Pain |
2.8% |
| Hypothyroidism |
2.4% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Hypertension |
1.6% |
| Nausea |
1.6% |
| Sleep Disorder |
1.6% |
| Adrenal Insufficiency |
1.2% |
| Bronchitis |
1.2% |
| Contraception |
1.2% |
| Hypersensitivity |
1.2% |
| Cardiac Disorder |
0.8% |
| Constipation |
0.8% |
| Depression |
0.8% |
| Immunosuppression |
0.8% |
|
| Hereditary Angioedema |
14.3% |
| Off Label Use |
7.1% |
| Therapy Change |
7.1% |
| Tooth Abscess |
7.1% |
| Vomiting In Pregnancy |
7.1% |
| Weight Decreased |
7.1% |
| Angioedema |
3.6% |
| Blood Creatinine Increased |
3.6% |
| Blood Glucose Increased |
3.6% |
| Candidiasis |
3.6% |
| Convulsion |
3.6% |
| Deep Vein Thrombosis |
3.6% |
| Drug Hypersensitivity |
3.6% |
| Gastric Ulcer |
3.6% |
| Hypertension |
3.6% |
| Hypovolaemic Shock |
3.6% |
| Inappropriate Schedule Of Drug Administration |
3.6% |
| Incorrect Drug Administration Rate |
3.6% |
| Injection Site Erythema |
3.6% |
| Mass |
3.6% |
|
